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Outcomes of Catheter Ablation for Atrial fibrillation in 
 Patients with Hypertrophic Cardiomyopathy
Lohit Garg, Syed Rafay Ali Sabzwari, Ghulam Akbar, Hiwot Ayele, Sahil Agrawal, Manyoo Agarwal,  
Jeffrey Gordon, Raman Dusaj, Talha Nazir, Babak Bozorgnia, Matthew Martinez
Department of Cardiology, Lehigh Valley Hospital, Allentown, PA
INTRODUCTION
•  Atrial fibrillation (AF) is common in adult patients with hypertrophic 
cardiomyopathy (HCM) and is associated with increased morbidity and mortality. 
•  Approximately one-third of patients with HCM develop AF during their lifetime. 
•  Catheter ablation can be effective in reducing the burden of AF in HCM patients.
•  However, there is paucity of data regarding the safety and outcomes of catheter 
ablation in these patients.
OBJECTIVE
•  We intend to study the safety and in-hospital outcomes of  
catheter ablation for atrial fibrillation in patients with hypertrophic 
cardiomyopathy. 
METHODS 
•  We queried the National Inpatient Sample (NIS) database to identify all adults 
patients > 18 years with HCM who underwent catheter ablation for AF between 
2003-2013.
•  Baseline demographics and clinical features were studied.
•  The primary outcome of interest was all cause  in-hospital mortality.
•  The secondary outcomes of interest were bleeding complications, pericardial 
complications, iatrogenic cardiac injury, vascular complications, pneumothorax 
and neurologic complications. 
Table 1: Complications associated with catheter ablation for AF in HCM patients
Outcome AF ablation (1,468)
Death 20 (1.4%)
Bleeding complications 167 (11.3%)
Pericardial complications 28 (1.9%)
Iatrogenic cardiac injury 107 (7.3%)
Vascular complications 18 (1.3%)
Hemothorax/Pneumothorax 20 (1.4%)
Neurologic/Stroke/TIA 5 (0.3%)
AF: Atrial fibrillation; TIA: Transient Ischemic Attack
RESULT 
•  We identified 1,468 HCM patients who underwent catheter ablation for AF 
between 2003-2013. 
•  The mean age of these patients was 62+/-15 years, 52 % were females, 
67.4% were Caucasians, and 78.7% were performed in teaching hospital. 
•  291 (19.8%) patients experienced procedure related complications, however 
in-hospital mortality was low (1.4%) (Table1). 
•  On multivariate analysis, age > 65 years (OR= 1.16; CI= 1.08-1.23; 
p<0.001), large hospital size (OR=1.44; CI=1.04-1.99; p=0.026), and 
teaching hospital (OR=1.34; CI= 1.14-1.50; p=0.002) were independent 
predictors of in-hospital complications.
LIMITATIONS
•  Retrospective design of the study and 
possibility of varying coding practices of the 
hospital.
•  Medication and procedural success data is 
unavailable due to administrative nature of  
the database. 
•  Long term follow up data is unavailable. 
CONCLUSION
•  HCM patients undergo AF ablation at relatively 
young age. 
•  One-fifth of the HCM patients who underwent AF 
ablation experienced in-hospital complications 
while in-hospital deaths were rare.
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